scorecardresearch
Add as a preferred source on Google
Monday, November 10, 2025
TopicCovid vaccines

Topic: Covid vaccines

Covid pandemic — Protests in France against ‘health pass’, New Zealand extends lockdown

ThePrint brings you some important global stories on the coronavirus pandemic.

India to have 18-22 crore vaccine doses by September, ZyCoV D could take longer to hit market

The increase in vaccine procurement is good news in terms of daily vaccination numbers, but govt's stated target of 1 crore daily vaccinations still some time away.

Zycov D is 66% effective against Delta variant of SARS-Cov-2, claims Zydus Cadila

Zydus' claim comes a day after it being given emergency use authorisation in India, and is the only vaccine approved for use in 12-18 years age group.

Covid vaccines for children could be available by September, Bharat Biotech & NIV say

Bharat Biotech CMD Dr Krishna Ella said final phase of clinical trial is over & they hope to get licence soon. NIV Director Dr Priya Abraham said vaccines may be available by Sept.

Covid vaccines less effective against Delta variant, UK study finds

The study results may fuel calls to give booster shots to the fully vaccinated. While UK is still deciding, US says those who got both doses will get a third shot after 8 months.

Covid cases in Southeast Asia plateaued over past month as India’s tally remained stable: WHO

South-East Asia Region reported over 799,000 new cases, a 5% decrease from last week, however, some countries in the Region continue to report a rise, including Sri Lanka, Thailand.

No clarity on India launch of single-dose J&J Covid jab as talks focus on indemnity hurdle

US pharmaceutical companies like Moderna, Pfizer and Johnson & Johnson have asked for indemnity against legal liability but the Government of India has not been inclined to give it.

Facilities at Bharat Biotech to be augmented to increase Covaxin supply, Mandaviya says

In a written reply to Rajya Sabha Friday, Health Minister Mansukh Mandaviya said that three Public Sector Enterprises will also be supported to manufacture Covaxin.

India unlikely to give indemnity to foreign vaccines, may consider only if shortage persists

Modi govt is not inclined to give Moderna or any other foreign vaccine manufacturer indemnity as long as the vaccine programme's target seems achievable by current supply.

Biden’s US promised Covid vaccines for India but here’s why they may never arrive

Covid vaccine talks between India and US seem to have reached a dead-end in the absence of consensus over indemnity issues.

On Camera

The govt’s ‘fix’ to speed up insolvency could add at least a year to the process

The proposed amendment to the Insolvency and Bankruptcy Code aims to reduce timelines and provide for a mechanism that involves minimal interaction with the court. It fails on both counts.

No more text-heavy ads, wider scope of services—ICAI’s ethics code overhaul to promote Indian CA firms

Open to public feedback until 26 November, the revised guidelines, among other changes, give CA firms more flexibility to advertise & promote their services.

‘Let them see’: Putin says new nuclear-powered missiles in the making, in message to Washington

At a ceremony felicitating Russian military engineers, Putin highlights Moscow’s 'parity' in defence technologies for the next century.

Bihar is where politics moves, and everything else stands still

Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.